Evaluation and Management of Noncardiac Comorbidities in Children With Congenital Heart Disease-Reference-Cited by-同舟云学术

Evaluation and Management of Noncardiac Comorbidities in Children With Congenital Heart Disease

Published:2022-11-01 Issue:Supplement 2 Volume:150 Page:
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Chowdhury Devyani¹²,Toms Rune³²,Brumbaugh Jane E.⁴,Bindom Sharell³,Ather Mishaal¹,Jaquiss Robert⁵,Johnson Jonathan N.⁶

Affiliation:

1. aCardiology Care for Children, Lancaster, Pennsylvania Nemours Cardiac Center

2. *These two co-first authors contributed equally to this manuscript

3. bDivision of Neonatal-Perinatal Medicine, Joe DiMaggio Children’s Hospital, Hollywood, Florida

4. cDivision of Neonatal Medicine

5. dDivision of Pediatric and Congenital Cardiothoracic Surgery, Children’s Medical Center, Dallas, Texas

6. eDivision of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic Children’s Center, Rochester, Minnesota

Abstract

Outcomes for patients with neonatal heart disease are affected by numerous noncardiac and genetic factors. These can include neonatal concerns, such as prematurity and low birth weight, and congenital anomalies, such as airway, pulmonary, gastrointestinal, and genitourinary anomalies, and genetic syndromes. This section will serve as a summary of these issues and how they may affect the evaluation and management of a neonate with heart disease. These noncardiac factors are heavily influenced by conditions common to neonatologists, making a strong argument for multidisciplinary care with neonatologists, cardiologists, surgeons, anesthesiologists, and cardiovascular intensivists. Through this section and this project, we aim to facilitate a comprehensive approach to the care of neonates with congenital heart disease.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2022-056415E/1389822/peds_2022056415e.pdf

Reference106 articles.

1. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants;Fenton;BMC Pediatr,2013

2. Centers for Disease Control and Prevention . WHO growth standards are recommended for use in the U.S. for infants and children 0 to 2 years of age. Available at: www.cdc.gov/growthcharts/who_charts.htm#/The%20WHO%20Growth%20Charts. Accessed November 30, 2019

3. New intrauterine growth curves based on United States data;Olsen;Pediatrics,2010

4. Ponderal index: a better definition of the ‘at risk’ group with intrauterine growth problems than birth-weight for gestational age in term infants;Fay;Aust N Z J Obstet Gynaecol,1991

5. Cardiopulmonary bypass in neonates weighing less than 2.5 kg: analysis of the risk factors for early and late mortality;Pawade;J Card Surg,1993